SCHEMBL30906487

SCHEMBL30906487

CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 3/20 0.53
▸ CXCR4 P61073 2/20 0.50
▸ CALCA P06881 2/20 0.50
▸ RAMP1 O60894 1/20 0.50
▸ NPY1R P25929 1/20 0.50
▸ NPY2R P49146 1/20 0.50
▸ NPY4R P50391 1/20 0.50
▸ NPY5R Q15761 1/20 0.50
▸ GLP1R P43220 11/20 0.48
▸ GIPR P48546 9/20 0.48
▸ GCGR P47871 3/20 0.48
▸ C5AR1 P21730 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30906519 0.96 NPY1R (0.54) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30906530 0.90 CALCA (0.54) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30906348 0.90 NPY1R (0.51) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30906505 0.87 NPY1R (0.58) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30906540 0.87 NPY1R (0.55) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30906357 0.86 NPY1R (0.57) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906406 0.86 NPY1R (0.56) NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30906366 0.85 NPY1R (0.53) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30684885 0.84 DPP3 (0.58) C5AR1
SCHEMBL30906418 0.84 NPY1R (0.57) NPY1RNPY2RNPY4RNPY5RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 — — EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 — — US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 — — WO disclosed
Send feedback